动脉药盒化疗在膀胱癌治疗中的临床研究  

The Clinical Research of Infusion Chemotherapy Via Arterial Port- Catheter System in the Treatment of Bladder Cancer

作　　者：李友河 

机构地区：[1]广东省从化市中医医院内二科,广东从化510900

出　　处：《中国医药指南》2013年第1期399-400,共2页Guide of China Medicine

基　　金：广州市卫生局医药卫生科技项目;项目编号:20121A041006

摘　　要：目的评价药盒动脉导管灌注治疗膀胱癌的疗效。方法将60例患者随即分为观察组和对照组,每组30例,观察组采用药盒动脉导管灌注治疗,对照组采用静脉化疗,比较两组疗效。结果观察组总有效率为76.7%,而静脉化疗组总有效率为46.7%,经比较有显著性差异(P<0.05),副作用较静脉化疗明显减轻。结论经药盒动脉导管灌注化疗治疗膀胱癌可提高患者临床疗效及生活质量,值得临床进一步研究。Objective To evaluate the efficacy of infusion chemotherapy via arterial Port-Catheter System（PCS） for bladder cancer.Methods Atotal of 60 patients with bladder cancer were randomized into two groups（30 cases each）,with the observation group were treated with infusion chemotherapy via arterial PCS and the control group underwent intravenous chemotherapy;The curative effects of t he 2 groups were t hen compared.Results The overall response rates of two group were 76.7%（the observation group） and 46.7%（the control group）,respectively.Clinical efficacy between the two groups showed significant differences（P0.05）.Conclusion The infusion chemotherapy via arterial PCS for bladder cancer can improve the clinical efficacy,and a further study is worthy to continue.

关 键 词：膀胱癌 导管药盒系统 临床疗效 

分 类 号：R737.14[医药卫生—肿瘤]